Breathing Tube-Free anesthesia could speed kidney transplant recovery
NCT ID NCT07377123
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new 'tubeless' anesthesia method (using a laryngeal mask and lighter sedation) to standard breathing-tube anesthesia in 60 kidney transplant patients. The goal is to see if it reduces the need for muscle relaxants and other drugs, and improves recovery. Participants will be followed for life to track long-term outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tubeless spontaneous ventilation anesthesia (a procedure using laryngeal mask and specific drugs like propofol, remifentanil, cisatracurium)
- What this could lead to
- If it works, this could lead to a safer, faster-recovering anesthesia method for kidney transplant patients, reducing side effects from muscle relaxants.
- What could go wrong
- This is a small, early-stage trial (60 people) at one center. The procedure may not be safer or more effective than standard anesthesia, and risks like breathing problems or inadequate anesthesia depth exist.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD (CHRONIC KIDNEY DISEASE) STAGE 5D are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may spot hidden kidney transplant rejection
- A drug given to organ donors may help kidneys work faster after transplant
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
- Blood test clues could make antifungal dosing safer for transplant patients
- New Two-Step therapy aims to stop chronic kidney transplant rejection
- Smartphone app and booklet could help kidney transplant patients stick to medications